I think the potential market for this drug has been greatly overstated. It's a specialty drug, and the market cap has gotten way ahead of itself. Even the best sales projections have a hard time supporting a share price in the $3.20 - $3.60 range. We're going lower.
- Forums
- ASX - By Stock
- PGL
- price target 3.50
price target 3.50
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
43.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.64M |
Open | High | Low | Value | Volume |
43.5¢ | 43.5¢ | 43.5¢ | $69.31K | 159.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 788030 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 95406 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 788030 | 0.435 |
2 | 100000 | 0.430 |
1 | 55597 | 0.425 |
1 | 83416 | 0.420 |
1 | 16000 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 95406 | 2 |
0.445 | 97049 | 5 |
0.450 | 128910 | 7 |
0.490 | 21811 | 2 |
0.510 | 20000 | 1 |
Last trade - 15.48pm 28/06/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online